Top compounds associated with response to LRRTM1


Feature Type Standardized
Nominal ANOVA
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.043 0.2
mRNA BRD-K03536150 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA fulvestrant CTRPv2 pan-cancer AAC 0.098 0.2
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.043 0.2
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC -0.044 0.2
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.044 0.2
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC 0.04 0.2
mRNA paclitaxel GDSC1000 pan-cancer AAC -0.065 0.2
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA tigecycline CTRPv2 pan-cancer AAC 0.059 0.2
Download CSV